EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI Hungary Ltd.
02 1Teva API India Private Ltd
03 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
04 1Aurobindo Pharma Limited
05 1CTX Lifesciences Pvt. Ltd.
06 1Cadila Pharmaceuticals Limited
07 1Catalent Micron Technologies, Inc.
08 1Divi's Laboratories Limited
09 2Glenmark Life Sciences Limited
10 1Hetero Labs Limited
11 1Jubilant Pharmova Limited
12 1MSN Laboratories Private Limited
13 1MYLAN LABORATORIES LIMITED
14 1Micro Labs Limited
15 1Tianish Laboratories Private Limited
16 1Vasudah Pharma Chem Limited
17 1Vasudha Pharma Chem Limited
18 2Venkata Narayana Active Ingredients Private Limited
19 1Viyash Life Sciences Private Limited
20 1YiChang HEC ChangJiang Pharmaceutical Co.,Ltd.
21 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
22 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
23 1Zydus Lifesciences Limited
01 4OLMESARTAN MEDOXOMIL
02 21Olmesartan Medoxomil
01 3China
02 1France
03 18India
04 1Israel
05 2U.S.A
NDC Package Code : 82231-116
Start Marketing Date : 2023-10-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 15894-0019
Start Marketing Date : 2015-12-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42419-034
Start Marketing Date : 2024-10-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-056
Start Marketing Date : 2012-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49587-110
Start Marketing Date : 2016-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-279
Start Marketing Date : 2013-09-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0011
Start Marketing Date : 2010-03-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52038-003
Start Marketing Date : 2010-06-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52038-006
Start Marketing Date : 2019-10-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0021
Start Marketing Date : 2012-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Olmesartan Medoxomil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olmesartan Medoxomil, including repackagers and relabelers. The FDA regulates Olmesartan Medoxomil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olmesartan Medoxomil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olmesartan Medoxomil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olmesartan Medoxomil supplier is an individual or a company that provides Olmesartan Medoxomil active pharmaceutical ingredient (API) or Olmesartan Medoxomil finished formulations upon request. The Olmesartan Medoxomil suppliers may include Olmesartan Medoxomil API manufacturers, exporters, distributors and traders.
click here to find a list of Olmesartan Medoxomil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olmesartan Medoxomil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olmesartan Medoxomil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olmesartan Medoxomil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olmesartan Medoxomil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olmesartan Medoxomil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olmesartan Medoxomil suppliers with NDC on PharmaCompass.
We have 22 companies offering Olmesartan Medoxomil
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?